Calibrator, Multi-Analyte Mixture(JIX)
多分析物混合キャリブレータ この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。
72 件
直近 2025.06.04
302 件
0 件
581 件
分類情報
| Product Code | JIX |
|---|---|
| デバイス名 | Calibrator, Multi-Analyte Mixture 多分析物混合キャリブレータ この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。 |
| デバイスクラス | クラス II |
| 21 CFR 規制番号 | 862.1150 |
| 審査区分 | 届出免除(510(k) Exempt) |
| 医療専門分野 | 臨床化学 |
| 定義 | - |
| フラグ | 該当なし |
| AI分析 | 本品は、臨床化学分野において複数の検査項目(分析物)を同時に対象とする混合物として構成されたキャリブレータであり、分析装置の測定値を既知の基準値に合わせて校正するために用いられます。米国ではクラスIIに分類されていますが、21 CFR 862.1150に基づき市販前届出(510(k))が免除される機器とされています。これは、リスクが比較的低く、既存の性能基準等により安全性・有効性が確保できると判断された機器であることを意味します。 米国市場での動向 本製品は510(k)届出が累計約300件、参入企業は約100社に上りますが、直近5年間の届出はなく、最新の判定は2016年5月となっています。不具合報告は累計約580件で、大半が不具合(Malfunction)に分類され、死亡報告は0件、傷害は7件です。主な問題としてはHigh Test Results、Low Test Results、Incorrect, Inadequate or Imprecise Result or Readingsが挙げられています。回収は累計約70件で、クラスIは確認されておらず、クラスIIが約40件、クラスIIIが約7件、直近5年では約10件、最新の回収は2026年7月に開始されています。 この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。 |
関連 product code
同じ 21 CFR 862.1150 に分類される product code(3 件)
FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。
米国での回収・承認・不具合報告
米国回収
全 72 件| 回収番号 | クラス | 回収開始日 | 企業 | 理由 | ステータス |
|---|---|---|---|---|---|
| Z-1840-2025 JIX | クラス II | 2025.04.24 | Mckesson Medical-Surgical Inc. Corporate Office | transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result. | 対応中 |
| Z-1759-2024 JIX | クラス II | 2024.03.05 | Randox Laboratories Ltd. | Randox Laboratories has identified that Inorganic Phosphate in Calibration Serum Level 3, CAL2351 & CAL10388, is running with a negative bias on RX Series instruments compared to other methods. | 対応中 |
| Z-1328-2024 JIX | クラス II | 2024.03.01 | Randox Laboratories Ltd. | The firm has realigned C3 and Haptoglobin in Liquid Protein Calibrators, IT2691, to reference material ERM-DA470k/IFCC. | 対応中 |
| Z-0753-2024 JIX | クラス II | 2023.11.20 | Randox Laboratories Ltd. | Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37¿C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples | 対応中 |
| Z-0752-2024 JIX | クラス II | 2023.11.20 | Randox Laboratories Ltd. | CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments compared to other methods experience a shift in Quality Control and patient sample recovery of up to 13%. | 対応中 |
| Z-0751-2024 JIX | クラス II | 2023.11.13 | Randox Laboratories Ltd. | There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on the IFU of Human Assayed Multi-Sera Level 2 (HN1530) for TBIC taget value and on IFU of Human Assayed Multi-Sera Level 3 (HE 1532) for Lipase target value. | 対応中 |
| Z-0609-2024 JIX | クラス II | 2023.10.26 | Siemens Healthcare Diagnostics Inc | RAPIDPoint 500 Systems Measurement Cartridges (with lactate) has the potential to affect the Sodium (Na+) sensor to produce a negative bias that could result in serious injury due to a delayed diagnosis of hypernatremia or unnecessary intervention for hyponatremia and result in iatrogenic hypernatremia especially if the true sodium result is near the thresholds of severe alterations, as well as cause a Question Result -----? error flag for multiple electrolytes on patient samples and quality control that may cause a delay of diagnosis or treatment. | 対応中 |
| Z-0608-2024 JIX | クラス II | 2023.10.26 | Siemens Healthcare Diagnostics Inc | RAPIDPoint 500 Systems Measurement Cartridges (with lactate) has the potential to affect the Sodium (Na+) sensor to produce a negative bias that could result in serious injury due to a delayed diagnosis of hypernatremia or unnecessary intervention for hyponatremia and result in iatrogenic hypernatremia especially if the true sodium result is near the thresholds of severe alterations, as well as cause a Question Result -----? error flag for multiple electrolytes on patient samples and quality control that may cause a delay of diagnosis or treatment. | 対応中 |
| Z-0607-2024 JIX | クラス II | 2023.10.26 | Siemens Healthcare Diagnostics Inc | RAPIDPoint 500 Systems Measurement Cartridges (with lactate) has the potential to affect the Sodium (Na+) sensor to produce a negative bias that could result in serious injury due to a delayed diagnosis of hypernatremia or unnecessary intervention for hyponatremia and result in iatrogenic hypernatremia especially if the true sodium result is near the thresholds of severe alterations, as well as cause a Question Result -----? error flag for multiple electrolytes on patient samples and quality control that may cause a delay of diagnosis or treatment. | 対応中 |
| Z-0606-2024 JIX | クラス II | 2023.10.26 | Siemens Healthcare Diagnostics Inc | RAPIDPoint 500 Systems Measurement Cartridges (with lactate) has the potential to affect the Sodium (Na+) sensor to produce a negative bias that could result in serious injury due to a delayed diagnosis of hypernatremia or unnecessary intervention for hyponatremia and result in iatrogenic hypernatremia especially if the true sodium result is near the thresholds of severe alterations, as well as cause a Question Result -----? error flag for multiple electrolytes on patient samples and quality control that may cause a delay of diagnosis or treatment. | 対応中 |
| Z-2448-2023 JIX | クラス II | 2023.07.19 | Randox Laboratories Ltd. | As part of the firm's ongoing quality monitoring (see internal complaint # OCC72574), Randox Laboratories have restandardized Ferritin in Liquid Protein Calibrators, IT2691, to reference material NISBC 19/118. The calibrators lots 2112IT-2116IT, packed into batches 627222, 627224, 634886 and 634887 have been reassigned as part of the restandardization. Following this restandardization, Ferritin results for Quality Control material and patient samples recovered erroneously higher than the targeted calibrator values by approximately +10% across the assay range following. | 対応中 |
| Z-1563-2021 JIX | クラス II | 2021.03.29 | Randox Laboratories Ltd. | Randox can confirm a positive bias for Total Bilirubin and Direct Bilirubin of up to +15% across the assay ranges when using calibrator CAL2351, lot 1162UE. The positive bias has been attributed to bilirubin instability in the calibrator and is evident in both Quality Control (QC) and Patient samples. | 終了 |
| Z-1295-2021 JIX | クラス II | 2021.02.18 | Ortho-Clinical Diagnostics, Inc. | Potential total iron-binding capacity (TIBC) results. The VITROS TIBC performance shift will start with the newest Generation (GEN) of VITROS Fe Slides (GEN 26), the potential shift in TIBC patient values of GEN 26 and above will be approximately 80 ug/dL lower across the measuring range than other available GENS of VITROS Fe Slides (GENs 22-25). | 終了 |
| Z-0536-2021 JIX | クラス II | 2020.11.02 | Chromsystems Instruments & Chemicals GmbH | Products do not meet stability criteria and may impact results. | 終了 |
| Z-0521-2021 JIX | クラス II | 2020.10.29 | Chromsystems Instruments & Chemicals GmbH | Calibrator lots may not meet stability criteria and could result in increased results of patient samples for cortisone. | 完了 |
| Z-1226-2020 JIX | クラス II | 2019.12.16 | Ortho Clinical Diagnostics Inc | Potential for Negatively Biased Na+ Urine Results Using Several Lots of VITROS Chemistry Products Calibrator Kit 2 | 終了 |
| Z-1261-2020 JIX | クラス II | 2019.11.19 | Siemens Healthcare Diagnostics, Inc. | Atellica CH: The Atellica¿ CH High Sensitivity CReactive Protein Calibrator (hsCRP CAL) is for in vitro diagnostic use in calibrating the hsCRP assay using the Atellica¿ CH Analyzer. | 終了 |
| Z-1260-2020 JIX | クラス II | 2019.11.19 | Siemens Healthcare Diagnostics, Inc. | Atellica and ADVIA hsCRP calibrator accuracy has drifted away from the reference materials (ERM-DA470/IFCC), which is causing a high bias on QC and patient sample recovery. | 終了 |
| Z-0283-2020 JIX | クラス II | 2019.08.09 | Randox Laboratories Ltd. | The assigned value for Rheumatoid Factor over recovers against the reference material RF serum, 1st British standard from NIBSC. Ref = 64/002. The calibrator values have been adjusted to re-align to the reference material. | 終了 |
| Z-2490-2019 JIX | クラス III(軽微) | 2019.07.12 | Randox Laboratories Ltd. | Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for calibrator lot 961UE onwards). | 終了 |
510(k)(市販前届出)
全 302 件| No. | 番号 | 機器名 | 申請者 | 決定日 | 種別 | 概要 |
|---|---|---|---|---|---|---|
| 1 | K161140 | VITROS Chemistry Products Calibrator Kit 3 | Ortho-Clinical Diagnostics, Inc. | 2016.05.20 | 簡略(Abbreviated) | |
| 2 | K153365 | ADVIA Chemistry Enzyme 1 Calibrator, ADVIA Chemistry Enzyme 2 Calibrator | Siemens Healthcare Diagnostics, Inc. | 2015.12.18 | 通常(Traditional) | |
| 3 | K151552 | ELITech Clinical Systems ELICAL 2, ELITech Clinical Systems ELITROL I, ELITech Clinical Systems ELITROL II | Elitechgroup | 2015.07.08 | 簡略(Abbreviated) | |
| 4 | K140790 | Dimension Vista Chemistry 1 Calibrator (CHEM 1 CAL), Dimension Vista Magnesium Flex reagent cartridge (MG) | Siemens Healthcare Diagnostics | 2015.06.15 | 通常(Traditional) | |
| 5 | K141388 | SYSTEM CALIBRATER | Beckman Coulter Ireland, Inc. | 2014.07.11 | 簡略(Abbreviated) | |
| 6 | K133330 | C.F.A.S. PROTEINS, C.F.A.S. PAC, PRECICONTROL CLINCHEM MULTI 1 & 2, PRECINORM PROTEIN & PRECIPATH PROTEIN | Roche Diagnostics | 2013.11.26 | 特別(Special) | |
| 7 | K130765 | ELITECH CLINICAL SYSTEMS ELICAL 2; ELITECH CLINICAL SYSTEMS ELITROL I, ELITECH CLINICAL SYSTEMS ELITROL II | Elitechgroup | 2013.04.04 | 簡略(Abbreviated) | |
| 8 | K123321 | DIMENSION CHEMISTRY III CALIBRATORY | Siemens Healthcare Diagnostics | 2013.02.15 | 通常(Traditional) | |
| 9 | K123372 | ABBOTT LIPID MULTI CONSTITUENT CALIBRATOR | Abbott Laboratories | 2013.01.14 | 通常(Traditional) | |
| 10 | K122398 | RAPIDPOINT 500 SYSTEM MEASUREMENT CARTRIDGE WITH CALIBRATORS | Siemens Healthcare Diagnostics, Inc. | 2012.10.12 | 通常(Traditional) | |
| 11 | K112834 | MULTI-CHEMISTRY STANDARD KIT, URIC ACID STANDARD KIT, URINE CHEMISTRY STARDAND KIT, URINE URIC ACID STANDARD KIT, CHOLES | Verichem Laboratories, Inc. | 2012.03.28 | 簡略(Abbreviated) | |
| 12 | K112029 | ELITECH CLINICAL SYSTEMS ELICAL 2, ELITECH CLINICAL SYSTEMS ELITROL I, ELITECH CLINICAL SYSTEMS ELITROL II MODEL CALI-05 | Elitechgroup | 2011.08.30 | 簡略(Abbreviated) | |
| 13 | K110394 | ATAC SERUM CALIBRATOR (DIRECT BILIRUBIN AND IRON) | Vital Diagnostics (Manufacturing) Ptyltd | 2011.06.09 | 簡略(Abbreviated) | - |
| 14 | K110251 | SYNCHRON MULTI CALIBRATOR | Beckman Coulter, Inc. | 2011.05.25 | 通常(Traditional) | |
| 15 | K103701 | ADVIA CHEMISTRY LIQUID SPECIFIC PROTEIN CALIBRATORS | Siemens Healthcare Diagnostics, Inc. | 2011.02.18 | 簡略(Abbreviated) | |
| 16 | K103171 | ELECSYS ANTI-TPO CALSET | Roche Diagnostics | 2011.02.11 | 通常(Traditional) | |
| 17 | K103403 | MULTICONSTITUENT CALIBRATOR | Abbott Laboratories | 2011.02.04 | 通常(Traditional) | |
| 18 | K103612 | DIMENSION VISA ENZ 2 CAL | Siemens Healthcare Diagnostics, Inc. | 2011.01.25 | 通常(Traditional) | |
| 19 | K101456 | ROCHE DIAGNOSTICS CALIBRATOR FOR AUTOMATED SYSTEMS, ROCHE DIAGNOSTICS CALIBRATOR CALIBRATOR FOR AUTOMATED SYSTEM | Roche Diagnostics | 2010.09.08 | 特別(Special) | |
| 20 | K101460 | LOCI 8 CALIBRATOR, MODEL KC 646 | Siemens Healthcare Diagnostics | 2010.07.09 | 簡略(Abbreviated) |
出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認
PMA(市販前承認)
この product code の PMA 情報はありません。
不具合報告(MAUDE)トレンド
米国不具合報告検索で詳しく見る出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。
出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
取得日: 2026.09.28
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。